165 related articles for article (PubMed ID: 38853507)
1. [Mechanisms Underlying the Propagation of α-Synuclein Seeds Derived from the Blood of Patients with α-Synucleinopathies].
Okuzumi A; Hatano T; Hattori N
Brain Nerve; 2024 Jun; 76(6):767-772. PubMed ID: 38853507
[TBL] [Abstract][Full Text] [Related]
2. The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease.
Miao Y; Meng H
Cell Commun Signal; 2024 Jan; 22(1):31. PubMed ID: 38216911
[TBL] [Abstract][Full Text] [Related]
3. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
[TBL] [Abstract][Full Text] [Related]
4. Transmission of α-synuclein seeds in neurodegenerative disease: recent developments.
Karpowicz RJ; Trojanowski JQ; Lee VM
Lab Invest; 2019 Jul; 99(7):971-981. PubMed ID: 30760864
[TBL] [Abstract][Full Text] [Related]
5. An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.
Serratos IN; Hernández-Pérez E; Campos C; Aschner M; Santamaría A
Mol Neurobiol; 2022 Jan; 59(1):620-642. PubMed ID: 34750787
[TBL] [Abstract][Full Text] [Related]
6. GV-971 attenuates α-Synuclein aggregation and related pathology.
Yu Z; Yang Y; Chan RB; Shi M; Stewart T; Huang Y; Liu Z; Lan G; Sheng L; Tian C; Yang D; Zhang J
CNS Neurosci Ther; 2024 Feb; 30(2):e14393. PubMed ID: 37563872
[TBL] [Abstract][Full Text] [Related]
7. Brain regions susceptible to alpha-synuclein spreading.
Guo YJ; Xiong H; Chen K; Zou JJ; Lei P
Mol Psychiatry; 2022 Jan; 27(1):758-770. PubMed ID: 34561613
[TBL] [Abstract][Full Text] [Related]
8. Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
Hansen C; Li JY
Trends Mol Med; 2012 May; 18(5):248-55. PubMed ID: 22503115
[TBL] [Abstract][Full Text] [Related]
9. The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses.
Jan A; Gonçalves NP; Vaegter CB; Jensen PH; Ferreira N
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361100
[TBL] [Abstract][Full Text] [Related]
10. Research Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson's Disease Treatment.
Kalsoom I; Wang Y; Li B; Wen H
Mini Rev Med Chem; 2023; 23(20):1959-1974. PubMed ID: 37198991
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson's disease.
Reyes JF; Ekmark-Léwen S; Perdiki M; Klingstedt T; Hoffmann A; Wiechec E; Nilsson P; Nilsson KPR; Alafuzoff I; Ingelsson M; Hallbeck M
Acta Neuropathol Commun; 2021 Mar; 9(1):46. PubMed ID: 33743820
[TBL] [Abstract][Full Text] [Related]
12. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
Henderson MX; Trojanowski JQ; Lee VM
Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
[TBL] [Abstract][Full Text] [Related]
13. Revisiting Alpha-Synuclein Pathways to Inflammation.
Lyra P; Machado V; Rota S; Chaudhuri KR; Botelho J; Mendes JJ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108299
[TBL] [Abstract][Full Text] [Related]
14. The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.
Benskey MJ; Perez RG; Manfredsson FP
J Neurochem; 2016 May; 137(3):331-59. PubMed ID: 26852372
[TBL] [Abstract][Full Text] [Related]
15. Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis.
Gadhe L; Sakunthala A; Mukherjee S; Gahlot N; Bera R; Sawner AS; Kadu P; Maji SK
Biophys Chem; 2022 Feb; 281():106736. PubMed ID: 34923391
[TBL] [Abstract][Full Text] [Related]
16. Spreading of alpha-synuclein between different cell types.
Ruf WP; Meirelles JL; Danzer KM
Behav Brain Res; 2023 Jan; 436():114059. PubMed ID: 35995264
[TBL] [Abstract][Full Text] [Related]
17. The Hidden Cell-to-Cell Trail of α-Synuclein Aggregates.
Neupane S; De Cecco E; Aguzzi A
J Mol Biol; 2023 Jun; 435(12):167930. PubMed ID: 36566800
[TBL] [Abstract][Full Text] [Related]
18. Progression of phosphorylated α-synuclein in Macaca fuscata.
Kawakami I; Motoda A; Hashimoto M; Shimozawa A; Masuda-Suzukake M; Ohtani R; Takase M; Kumashiro M; Samejima K; Hasegawa M
Brain Pathol; 2021 Sep; 31(5):e12952. PubMed ID: 33754430
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation.
Tavassoly O; Del Cid Pellitero E; Larroquette F; Cai E; Thomas RA; Soubannier V; Luo W; Durcan TM; Fon EA
Neurotherapeutics; 2021 Apr; 18(2):979-997. PubMed ID: 33713002
[TBL] [Abstract][Full Text] [Related]
20. Associations Between APOE Variants, Tau and α-Synuclein.
Rodriguez-Vieitez E; Nielsen HM
Adv Exp Med Biol; 2019; 1184():177-186. PubMed ID: 32096038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
